Invention Grant
![[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof](/docs/US/2024-03-05/US11919896B2/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof
-
Application No.: US17263416Application Date: 2019-08-23
-
Publication No.: US11919896B2Publication Date: 2024-03-05
- Inventor: Weiwei Mao , Wenyuan Qian , Xuejian Zheng , Guoping Hu , Changqing Wei , Jian Li , Shuhui Chen
- Applicant: Zhuhai United Laboratories Co., Ltd.
- Applicant Address: CN Guangdong
- Assignee: ZHUHAI UNITED LABORATORIES CO., LTD.
- Current Assignee: ZHUHAI UNITED LABORATORIES CO., LTD.
- Current Assignee Address: CN Guangdong
- Agency: Lucas & Mercanti, LLP
- Priority: CN 1810968207.6 2018.08.23
- International Application: PCT/CN2019/102209 2019.08.23
- International Announcement: WO2020/038457A 2020.02.27
- Date entered country: 2021-01-26
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P19/02
![[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof](/abs-image/US/2024/03/05/US11919896B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed are a [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and an application thereof in preparing a drug for treating a disease related to JAK1 or/and TYK2. Specifically, the present invention relates to a compound represented by formula (I), or an isomer or pharmaceutically acceptable salt thereof. (I)
Public/Granted literature
- US20210155621A1 [1,2,4]TRIAZOLO[1,5-A]PYRIDINE COMPOUND AS JAK INHIBITOR AND USE THEREOF Public/Granted day:2021-05-27
Information query
